Clinical Trial Management System (CTMS) Market Size, Share, Growth Analysis, By Type(Site and Enterprise), By Component(On premise, Web-based CTMS, and Cloud based), By End User(Software, and Services), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35G2089 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
87
|Figures:
76
Clinical Trial Management System (CTMS) Market Insights
The increase in decentralised clinical trials, higher CTMS integration with other systems like hospital information systems, rising adoption of CTMS in clinical trials, surge in clinical trial outsourcing, increase in investment by biotechnology & pharmaceutical companies, and increase in government support & funding for research trials are additional factors driving the growth of the global clinical trial management system market. Over the forecast period, these factors are expected to drive market growth.
US Clinical Trial Management System (CTMS) Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Enterprise
Fastest Growth
site
Growth Rate
To get more reports on the above market click here to Buy The Report
Clinical Trial Management System (CTMS) Market Segmental Analysis
Global Clinical Trial Management System (CTMS) Market is segmented based on the Type, Delivery Mode, Component, end user, and region. Based on Type the market is segmented into Site, Enterprise. Based on the Delivery Mode into on premise, Web-based CTMS, Cloud based. Based on the Component, it is segmented into Software, Services. Based on the end user, it is segmented into Clinical Research Organization, Pharmaceutical, Health care providers, Biopharmaceutical companies. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Clinical Trial Management System (CTMS) Market Analysis by Product Type
Due to its increasing contribution to the global economy, which is forecasted to continue in the future, the enterprise-based category has emerged as the largest market on a type-by-type basis. The market is anticipated to continue growing during the forecast period due to the constantly accelerating technology advancement that is seen throughout the healthcare industry. To meet the needs of potential customers, a number of businesses are taking steps to improve the infrastructure and standard of service in the healthcare sector.
The other segment that has shown considerable growth is the site-based sector, which is expected to perform tremendously in the coming years. The market size has increased significantly due to the rising number of people suffering from chronic diseases. Numerous clinical studies have been promoted as a result of the public's growing acceptance of innovative technology. These trials help the research and development initiatives undertaken by the major market participants with the goal of bringing new medicines to the market.
Clinical Trial Management System (CTMS) Market Analysis by End Use
The biopharmaceutical and pharmaceutical markets is forecast to be the largest market on the basis of end users due to its major contribution to the clinical trial management system. The rapid development of the clinical trial management system, which has become an essential component of the entire health care system and necessitates proper organisation and management of the massive amount of data or information fed into the system every day, is due primarily to the pharmaceutical company's fast developments. The segment of clinical research organisations, on the other hand, has experienced tremendous growth as a result of the rapidly rising number of patients with chronic diseases, which calls for special attention from the major market players in order to conduct clinical trials with the goal of bringing cutting-edge medications to the market.
To get detailed analysis on other segments, Request For Free Sample Report
Clinical Trial Management System (CTMS) Market Regional Insights
Due to its promising legal framework, North America currently has a dominance on the clinical trial management system (CTMS) market. The expansion of the clinical trial management system (CTMS) market in the region will also be aided by the increase in pharmaceutical companies' investments over the duration of the forecast period.
In the upcoming years, Asia Pacific is anticipated to grow at the fastest CAGR. This is because there are more R&D activities taking place in the area, there is a huge patient pool available, more clinical trials are being done around the area, and more clinical studies are being outsourced. Asia provides a less expensive method for doing clinical research investigations. During the forecast period, it is expected that this element will boost the market place.
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Clinical Trial Management System (CTMS) Market Dynamics
Clinical Trial Management System (CTMS) Market Drivers
Rapid Advancements of CTMS Solutions to Boost Market Growth
- The health science sectors implement a huge number of clinical trials, and this number is growing every day. The rapid development of this system is responsible for this system's phenomenal growth. A significant market growth component that is pushing revenue to record highs is the rising number of people suffering from rare and chronic diseases.
- The government is actively assisting the major market players in carrying out several R&D projects with the goal of introducing new medications to the market. The government funding that is available for running clinical studies has also significantly increased the size of the market. Clinical trial management systems are used to manage the massive amount of data that research centers collect.
Clinical Trial Management System (CTMS) Market Restraint
- High Cost associated with Clinical Trials to Hinder Market Growth
A common challenge for the major market players is the large amount of financial assistance needed to conduct a successful clinical trial. The development of the clinical trial management system, which is used to process the data received once the process is complete, is put under pressure as a result. The length of time needed to complete a clinical study also places a heavy financial burden on the major market players, which is challenging to manage in the long run.
- The growth for clinical trial management systems faced significant obstacles due to the professionals' lack of experience and expertise. During the forecast period, a number of challenges, including safety concerns, ineffective site selection, bad trial execution, and inadequate research design, emerge as the market's main obstacles to growth.
Request Free Customization of this report to help us to meet your business objectives.
Clinical Trial Management System (CTMS) Market Competitive Landscape
The competitive landscape for the market for clinical trial management systems (CTMS) contains information from a rival. Included information includes the company's executive summary, financials, revenue generated, market potential, investments in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product breadth and depth, and application dominance. Only the firms' emphasis on the clinical trial management system (CTMS) industry is covered by the data points mentioned above.
Clinical Trial Management System (CTMS) Market Top Player's Company Profiles
-
Medidata Solutions Inc.
-
BioClinica Inc.
-
PRA Health Sciences Inc.
-
DATATRAK International Inc.
-
Dassault Systèmes SA
-
Bioclinica (eClinical Solutions LLC)
-
Merge Healthcare Inc.
-
eResearch Technology Inc. (ERT)
-
ArisGlobal LLC
-
Forte Research Systems Inc.
-
MedNet Solutions Inc.
-
Bio-Optronics Inc.
-
Veeva Systems Inc.
-
OpenClinica LLC
-
MasterControl Inc.
-
Anju Software Inc.
-
IQVIA Inc.
Clinical Trial Management System (CTMS) Market Recent Developments
- In March 2022, THREAD and Amazon Web Services have agreed to work together. AWS will help in the development of new THREAD platform features by providing scalable automation and integrated AI to enable quicker and more effective trials by enabling higher quality data collecting throughout the lifecycle of the clinical study.
- In January 2022, Launch of Clarify Trials cloud-based software by Clarify Health. As they negotiate the Food and Drug Administration's (FDA) 2020 recommendation to promote diversity in clinical trials, this solution enables life sciences businesses and clinical research organisations (CROs) to proactively minimise health inequalities without excessive trial delays, budget overruns, or protocol revisions.
Clinical Trial Management System (CTMS) Key Market Trends
- Complex clinical trials are conducted by biotech, pharmaceutical, and other research-focused life science businesses in the development of novel drugs and medical technologies that aid in the treatment of numerous chronic diseases. These clinical trials have become more complicated in recent years as a result of high research and development (R&D) expenses, vast data collection, and the application of cutting-edge technologies. Because CTMS acts as a consolidated, web-based enterprise resource to support complex clinical research investigations in real-time, its demand is on the increase. In accordance with this, the market is expanding due to an older population, rising preferences for regenerative medicine, and the use of tailored treatments. In addition, market participants are creating automated CTMS solutions to enhance productivity, study reconciliation, and data quality, which is expected to have a positive impact on the sector's forecast.
Clinical Trial Management System (CTMS) Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to the global clinical trial management system (CTMS)market analysis, In the upcoming years, market growth is predicted to be boosted by the rising number of decentralised clinical studies. These trials, which frequently make use of telemedicine tools, are also known as virtual, digital, mobile, siteless, and remote trials. For example, Labcorp's decentralised clinical trials (DCTs) solution provides a range of options for designing and implementing decentralised clinical trials, along with the appropriate tools, services, and infrastructure. It is also predicted that increased product availability from important enterprises will spur market expansion. To effectively organise and oversee clinical trials, Rave CTMS by Medidata, for instance, provides an intelligent automation and workflow management solution.
| Report Metric | Details |
|---|---|
| Forecast period | 2024-2031 |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
| Historical Year | 2019 |
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Clinical Trial Management System (CTMS) Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Clinical Trial Management System (CTMS) Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Clinical Trial Management System (CTMS) Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Clinical Trial Management System (CTMS) Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Clinical Trial Management System (CTMS) Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Clinical Trial Management System (CTMS) Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
